Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

  • This share is currently suspended. It was suspended at a price of 0.25
  • There is currently no data for TLY

Schedule One - Totally plc

15 Mar 2016 07:30

RNS Number : 0974S
AIM
15 March 2016
 

 

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

Totally plc

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES):

 

Lighterman House

26-36 Wharfdale Road

London N1 9RY

United Kingdom

 

COUNTRY OF INCORPORATION:

 

England and Wales

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

 

http://www.totallyplc.com

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

 

Totally plc ("Totally" or the "Company") is a provider of innovative solutions to the healthcare sector, both to the National Health Service and private sector companies, to help patients better understand healthcare options, promote self-care and aid long term behavioural change which in turn impact on lifestyle and reliance on healthcare solutions. The Company achieves this principally through its wholly-owned subsidiary, Totally Health Limited, which was established in 2011 specifically to provide innovative healthcare solutions. The Company's main country of operation is the UK.

 

The Company has conditionally agreed to acquire the entire issued share capital of Premier Physical Healthcare Limited ("Premier") for a maximum consideration of £6.75 million based on the financial performance of Premier (the "Acquisition"). Pursuant to Rule 14 of the AIM Rules for Companies, the Acquisition constitutes a reverse takeover. Shareholder approval is being sought at a general meeting to approve the admission of the Company's entire issued and to be issued ordinary share capital to trading on AIM on completion of this transaction.

 

Premier is incorporated and registered in England and Wales and is a provider of physical healthcare services to both public and private patients. Since its establishment in 1997, Premier has offered physiotherapy, podiatry and ergonomics services to a variety of clients.

 

Premier provides a comprehensive range of treatments and advice for musculoskeletal injuries and conditions. Premier's clinical staff are either chartered physiotherapists, orthopaedic and rheumatology rehabilitation consultants or state registered podiatrists. The majority of Premier's revenue is derived from the provision of physiotherapy and podiatry to National Health Service patients. Premier's main country of operation is the UK.

 

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

 

Number of securities to be admitted: 19,994,953

 

Type and nominal value of the securities: Ordinary Shares of 10p each in the Company

 

Issue price: 62p per Ordinary Share

 

Shares to be held in treasury: None

 

There are no restrictions as to transfer of the securities

 

CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

 

Capital to be raised on Admission: £6.20 million raised via a subscription

 

Anticipated market capitalisation on Admission: £12.40 million

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

 

44.55 per cent.

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES (INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED:

 

None

 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

 

Robert (Bob) Holt OBE

Chairman

Wendy Jayne Lawrence

Chief Executive Officer

Donald (Don) Ahelan Baladasan

Finance Director

Anthony (Tony) Rhys Bourne

Non-Executive Director

Michael (Mike) Greig Rogers

Non-Executive Director

 

 

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

 

Before Admission

After Admission

Shareholder

Ordinary Shares

%

Ordinary Shares

%

Unicorn Asset Management Limited

900,000

9.01

4,850,000

24.26

Seneca Partners Limited

900,000

9.01

2,916,000

14.58

Schroders Plc

515,000

5.15

1,995,000

9.98

Miton Asset Management Limited

900,000

9.01

1,800,000

9.00

Optiva Securities Limited

900,000

9.01

1,198,710

6.00

Livingbridge VC LLP

900,000

9.01

900,000

4.50

Robert (Bob) Holt

600,000

6.01

800,000

4.00

 

 

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

 

Dividends of £36,450 have been paid by Premier to each of Wayne Llewellyn and Raphael Leal within the 12 months preceding the date of the admission document. Wayne Llewellyn and Raphael Leal are the Chief Executive Officer and Chief Financial Officer of Premier and are also Premier's major shareholders.

 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

 

(i) 31 December

(ii) 30 June 2015 for Totally / 30 September 2015 for Premier

(iii) 30 June 2016 (annual report for the period ended 31 December 2015)

30 September 2016 (interim report for the period ended 30 June 2016)

30 June 2017 (annual report for the period ended 31 December 2016)

 

EXPECTED ADMISSION DATE:

 

1 April 2016

 

NAME AND ADDRESS OF NOMINATED ADVISER:

 

Allenby Capital Limited

3 St. Helen's Place

London

EC3A 6AB

United Kingdom

 

NAME AND ADDRESS OF BROKER:

 

Allenby Capital Limited

3 St. Helen's Place

London

EC3A 6AB

United Kingdom

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

 

Copies of the admission document, which will contain full details about the Company and the admission of its securities, will be available from the registered office of the Company and at the offices of Allenby Capital Limited, 3 St. Helen's Place, London EC3A 6AB during normal business hours on any weekday (Saturdays and public holidays excepted) for a period of one month from the date of admission.

 

The admission document will also be available to download from the Company's website www.totallyplc.com

 

DATE OF NOTIFICATION:

 

15 March 2016

 

NEW/ UPDATE:

 

NEW

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PAAEAKDSFLXKEEF
Date   Source Headline
7th Jul 20257:00 amRNSCancellation - Totally Plc
9th Jun 20257:00 amRNSAdministration and Director Resignations
6th Jun 20251:00 pmRNSIntention to Appoint Administrators and Suspension
6th Jun 20251:00 pmRNSSuspension - Totally plc
30th May 20252:25 pmRNSHolding(s) in Company
29th May 20252:10 pmRNSHolding(s) in Company
23rd May 20257:00 amRNSUpdate on Strategic Review
2nd May 20257:00 amRNSHolding(s) in Company
1st May 20257:00 amRNSCommencement of Strategic Review
1st May 20257:00 amRNSTrading Update
27th Mar 20257:00 amRNSDirector/PDMR Shareholding
25th Mar 20253:35 pmRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
5th Mar 20253:15 pmRNSHolding(s) in Company
3rd Mar 20259:00 amRNSHolding(s) in Company
3rd Mar 20259:00 amRNSHolding(s) in Company
28th Feb 20257:00 amRNSHolding(s) in Company
27th Feb 20257:00 amRNSContract Renewals
26th Feb 20251:00 pmRNSHolding(s) in Company
25th Feb 20256:00 pmRNSHolding(s) in Company
25th Feb 202511:00 amRNSHolding(s) in Company
21st Feb 20257:00 amRNSDirectorate Change
20th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20257:00 amRNSOutlook Update
13th Jan 20257:00 amRNSDirectorate Change
7th Jan 20254:15 pmRNSHolding(s) in Company
3rd Dec 20244:00 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSInterim Results
5th Nov 20245:00 pmRNSHolding(s) in Company
31st Oct 20247:00 amRNSUpdate on Banking Facility
17th Oct 20247:00 amRNSNotice of Interim Results & Investor Presentation
27th Sep 20245:45 pmRNSResult of AGM
27th Sep 20249:00 amRNSAGM Statement
27th Sep 20247:00 amRNSContract Win and Extension
20th Sep 20242:30 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSDirector/PDMR Shareholding
4th Sep 20241:30 pmRNSPosting of Annual Report and Notice of AGM
4th Sep 20247:00 amRNSDirector/PDMR Shareholding
29th Aug 20247:00 amRNSContract Wins
27th Aug 20246:16 pmRNSHolding(s) in Company
27th Aug 20246:13 pmRNSHolding(s) in Company
2nd Aug 20249:30 amRNSHolding(s) in Company
2nd Aug 20247:00 amRNSDirectorate Change
1st Aug 202410:45 amRNSHolding(s) in Company
24th Jul 20247:00 amRNSDirectorate Change
24th Jul 20247:00 amRNSPreliminary results
23rd Jul 20247:00 amRNSContract extensions and win
22nd Jul 20243:30 pmRNSHolding(s) in Company
18th Jul 20247:00 amRNSNotice of Results
11th Jul 20247:00 amRNSContract extensions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.